Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, EpiSciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.

Abstract : Certain indirubin derivatives are potent cyclin-dependent kinase (CDK) and glycogen synthase kinase (GSK-3β) inhibitors and may be effective against various cancers. We evaluated the effects of aloisine A, alsterpaullone, aminopurvalanol, indirubin-3'-oxime, 6-Br-indirubin-3'-oxime, kenpaullone, olomoucine and roscovitine on cell proliferation, prostate-specific antigen (PSA) expression, androgen receptor (AR) activation, and GSK-3β and β-catenin expression in androgen-dependent LNCaP human prostate cancer cells. Effects were also evaluated in MDA-kb2 human breast cancer cells containing an AR-responsive luciferase construct. Steroid-deprived LNCaP cells were exposed to indirubins±dihydrotestosterone (DHT, 0.1 nM) and cell proliferation was assessed by MTT assay after 120 h. PSA expression was determined by real-time quantitative RT-PCR after 24h. Cytoplasmic and nuclear GSK-3β/β-catenin expression and phosphorylation status was determined by Western blotting. Effects on MDA-kb2 luciferase expression were determined after 24h using Steady-Glo (Promega). Indirubin-3'-oxime, 6-Br-indirubin-3'-oxime, alsterpaullone and kenpaullone increased LNCaP cell proliferation and PSA expression (0.03-1 μM; apoptosis occurred >1 μM), whereas aminopurvalanol significantly (p<0.05) reduced DHT-stimulated PSA expression (31%) at 1 nM. The other indirubin derivatives had no effect. The same was observed for induction of AR-dependent MDA-kb2 luciferase expression. Kenpaullone (1, 3 μM) decreased the active- and increased the inactive form of cytoplasmic GSK-3β, and increased nuclear AR and β-catenin accumulation. Flutamide (10 μM), unexpectedly, also strongly increased nuclear β-catenin accumulation. Indirubin derivatives that were potent GSK-3β inhibitors (relative to CDK1) stimulated LNCaP cell proliferation and other androgenic responses, suggesting (in a cancer treatment context) these compounds may increase AR-dependent prostate cancer growth if not used within an appropriate therapeutic dose-range.
Document type :
Journal articles
Complete list of metadata
Contributor : Nancy Laflamme Connect in order to contact the contributor
Submitted on : Monday, August 6, 2012 - 8:11:55 PM
Last modification on : Monday, October 8, 2018 - 5:44:05 PM




Patricia Rivest, Martin Renaud, J Thomas Sanderson. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.. Chemico-Biological Interactions, Elsevier, 2011, 189 (3), pp.177-85. ⟨10.1016/j.cbi.2010.11.008⟩. ⟨pasteur-00722979⟩



Record views